Email Us
View Reports

Global Animal Therapeutics and Diagnostics Market Analysis with Forecasts to 2022 | Growth Opportunities

  • ID : 1957934763  |  
  • Published : Feb-2017  |  
  • Region : Global  |  
  • Pages : 256   |  
  • Publisher : BCC Research

Report Scope:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

Report Includes:

- An overview of the global markets for animal therapeutics and diagnostics

- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021

- Details about products currently in the market

- Analysis of the competitive environment

- A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market

- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities

- Profiles of major players in the industry

Table of Contents

Chapter 1 INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

INTENDED AUDIENCE

SCOPE OF REPORT

INFORMATION SOURCES

RELATED BCC RESEARCH REPORTS

ANALYST'S CREDENTIALS

BCC RESEARCH WEBSITE

DISCLAIMER

Chapter 2 SUMMARY

Chapter 3 INDUSTRY OVERVIEW

Chapter 4 ISSUES AFFECTING THE MARKET

Chapter 5 ANIMAL VACCINES

Chapter 6 ANIMAL PHARMACEUTICAL PRODUCTS

Chapter 7 ANIMAL FEED ADDITIVES

Chapter 8 ANIMAL DIAGNOSTICS

Chapter 9 MARKET SUMMARY

Chapter 10 PATENT ANALYSIS

Chapter 11 COMPANY PROFILES

MARKET OVERVIEW

LEADING MANUFACTURERS AND SUPPLIERS

ANIMAL ANATOMY AND PHYSIOLOGY

ANIMAL POPULATIONS IN THE UNITED STATES

ANIMAL POPULATIONS BY COUNTRY

ZOONOTIC DISEASES

REPRODUCTIVE SYSTEM

AVIAN ANATOMY

COMPANION ANIMALS

FOOD PRODUCTION ANIMALS

DOGS

CATS

HORSES

CATTLE

SWINE

SHEEP

GOATS

Livestock Production - Top States

OVERVIEW

LEGAL AND REGULATORY ISSUES

BIOTECHNOLOGY IN ANIMAL HEALTH

ANIMAL OBESITY

TRENDS IN COMPANION PET OWNERSHIP

ANIMAL HEALTH INSURANCE

ADVANCED MEDICAL PROCEDURES

LIFE CYCLE APPROACH

DEMAND IN THE VETERINARY SERVICE INDUSTRY

REGULATORY AGENCIES INVOLVED IN ANIMAL HEALTH AND WELFARE

ANTIBIOTIC USE AND RESISTANCE IN PRODUCTION ANIMALS

MINIMALLY AND HIGHLY REGULATED PRODUCTS

ANIMAL DRUG USER FEE ACT OF 2003

ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA II)

ANIMAL DRUG USER FEE AMENDMENTS OF 2013 (ADUFA III)

ANIMAL CLONING

PROBIOTICS

CAUSES

WEIGHT REDUCTION

Food and Drug Administration (FDA)

FDA's Center for Veterinary Medicine (CVM)

U.S. Department of Agriculture (USDA)

European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP)

Australian Pesticides and Veterinary Medicines Authority (APVMA)

The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil

FDA's Antimicrobial Restrictions

Losing Livestock

Corporate Response Concerning Responsible Use

Therapeutic Use

Resistance

Human Side Effects

Microbial Ecology

Agriculture and Food Research Initiative

Levels of Contaminated Meats in the U.S.

Movement for Lower Amounts of Antibiotics in Livestock Production

OVERVIEW

GLOBAL MARKET ANALYSIS AND CONSIDERATIONS

PRODUCT INTRODUCTION

COMPANION ANIMALS

PRODUCTION ANIMALS

GLOBAL MARKET BY GEOGRAPHICAL REGION

COMPETITIVE SUMMARY

ACTIVE IMMUNITY

PASSIVE IMMUNITY

OTHER TYPES

VIRUSES

VACCINE PROVIDERS

COMPANION ANIMAL VACCINES MARKET ANALYSIS

VIRUSES AND PRIONS

VACCINE PROVIDERS

PRODUCTION ANIMAL VACCINE MARKET ANALYSIS

Adenovirus

Avian Influenza

Coronavirus

Distemper

Eastern Equine Encephalitis

Equine Viral Arteritis

Feline Calicivirus and Feline Herpes Virus

Feline Immunosuppressive Virus

Feline Infectious Peritonitis Virus

Feline Leukemia Virus

Hendra Virus

Infectious Hepatitis

Internal Papillomatosis of Parrots

Newcastle Disease

Pacheco's Disease

Parainfluenza Virus

Paramyxoviruses

Parvovirus

Polyomavirus

Poxviruses

Psittacine Beak and Feather Disease

Rabies

Reovirus

West Nile Virus

Boehringer Ingelheim/Vetmedica

Elanco

Merck Animal Health

Merial

Zoetis

Avian Pneumovirus

Bovine Spongiform Encephalopathy

Bovine Viral Diarrhea

Classical Swine Fever

Foot and Mouth Disease

Furunculosis

Infectious Pancreatic Necrosis

Marek's Disease

Pathogenic Avian Influenza

Q Fever

Vesicular Stomatitis

Bayer

Boehringer Ingelheim

Elanco

Merck & Co.

Merial

Zoetis

OVERVIEW

GLOBAL MARKET ANALYSIS AND CONSIDERATIONS

PRODUCT INTRODUCTIONS

COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS

MARKETS BY GEOGRAPHICAL REGION

COMPETITIVE SUMMARY

ALLERGY AND RESPIRATORY DRUGS

ANTI-INFECTIVES AND ANTIFUNGALS

ANTI-INFLAMMATORIES AND ANALGESICS

METABOLIC AND ENDOCRINE DISORDER DRUGS

PARASITICIDES

PSYCHOTROPIC MEDICATIONS

OTHER PHARMACEUTICALS

Companion Animals: Allergy and Inflammatory Diseases

Target Species and Providers

Allergy and Respiratory Market Analysis

Companion Animals - Bacterial Infections

Production Animals - Bacterial Infections

Providers

Anti-Infectives Market Analysis

Providers

Anti-Inflammatory Market Analysis

Metabolic Diseases and Endocrine Disorders

Providers

Metabolic Drug Market Analysis

Companion Animals - Parasitic Diseases

Production Animals - Parasitic Disease Example

Providers

Parasiticide Market Analysis

Providers

Natural Remedies

Psychotropic Market Analysis

Companion Animals - Other Diseases

Providers

Dental

Other Pharmaceuticals Market Analysis

Allergies

Arthritis

Asthma

Dermatitis

Eosinophilic Granuloma Complex

Gout

Boehringer Ingelheim

Elanco

Heska

Huvepharma

Virbac

Zoetis

Black Tongue

Bordetella

Brucellosis

Campylobacteriosis

Chlamydia

Leptospirosis

Lyme Disease

Q Fever

Respiratory Mycoplasmosis

Spirochaetaceae

Tetanus

Anthrax

Blackleg

Conjunctivitis

Tetanus

Ehrlichia Ruminantium (previously known as Heartwater)

Pneumonia

Bayer

Boehringer Ingelheim

ECO

Elanco

Esteve

Merck Animal Health

Merial - Sanofi

Virbac

Zoetis

Aratana Therapeutics

Bayer

Boehringer Ingelheim

Elanco

Esteve

Merck Animal Health

Merial

Zoetis

Cushing's Syndrome

Diabetes Mellitus

Thyroid Disease

Pancreatitis

Metabolic Bone Disease in Birds

Aratana Therapeutics

Bayer

Boehringer Ingelheim

Merck

Merial

Virbac

Zoetis

Ear Mites

Fleas

Heartworm

Hemotropic Mycoplasmas (formerly Hemobartonellosis)

Feline Scabies

Lice

Sarcoptic Mange

Worms

Texas Cattle Fever

Bayer

Beaphar

Boehringer Ingelheim

ECO

Elanco

Huvepharma

Merck Animal Health

Merial

Virbac

Zoetis

Elanco

Vetoquinol

Zoetis

Equine Protozoal Myelitis

Leptospirosis and Equine Recurrent Uveitis

Urinary Diseases

Glomerulonephritis

Feline Lower Urinary Tract Disease

Neoplastic Disease

Heart Disease

Inflammatory Bowel Disease

Bayer

Boehringer Ingelheim

Elanco

Esteve

HbO2 Therapeutics LLC

Merck Animal Health

Merial

Virbac

Zoetis

OVERVIEW

GLOBAL MARKET ANALYSIS AND CONSIDERATIONS

PRODUCT INTRODUCTIONS

COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS

MARKETS BY GEOGRAPHICAL REGION

COMPETITIVE SUMMARY

AMINO ACIDS

MEDICINAL ADDITIVES

NUTRITIONAL SUPPLEMENTS

VITAMINS AND MINERALS

Providers

Amino Acid Market Analysis

Providers

Medicinal Feed Additive Market Analysis

Providers

Nutritional Supplement Market Analysis

Providers

Vitamin and Mineral Market Analysis

Adisseo - Bluestar

Ajinomoto

Boehringer Ingelheim

Evonik

Novus International

ECO

Elanco

Huvepharma

Merck

Merial

Phibro Animal Health

Zoetis

Adisseo - Bluestar

Bayer

BASF

Beaphar

Boehringer Ingelheim

DSM Nutritional Products

Elanco

Esteve

Heska

Mosaic

Virbac

Adisseo - Bluestar

BASF

Beaphar

DSM Nutritional Products

Merck Animal Health

Zoetis

OVERVIEW

GLOBAL MARKET ANALYSIS AND CONCLUSION

PRODUCT PROVIDERS AND DESCRIPTIONS

PRODUCT SEGMENTS

COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS

MARKETS BY GEOGRAPHICAL REGION

COMPETITIVE SUMMARY

ABAXIS

BEAPHAR

HESKA

IDEXX

MERCK ANIMAL HEALTH

VIRBAC

ZOETIS

DIAGNOSTIC RAPID TESTING MARKET ANALYSIS

MARKET ANALYSIS OF DIAGNOSTIC ANALYZERS AND CONSUMABLES

MARKET ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT

GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANALYSIS

COMPETITIVE ANALYSIS

MARKETS BY USE OR ANIMAL GROUP

MARKETS BY WORLD REGION

OVERVIEW

INNOVATION IN DRUG DELIVERY

PATENT PRODUCT SEGMENTS

TRANSDERMAL (SPRAY-ON) DRUGS

SUBLINGUAL (UNDER THE TONGUE) DRUGS

EFFERVESCENT TABLET VACCINE DELIVERY

STERILIZATION METHODS

PATENTS FILED BY YEAR

INTERNATIONAL PATENTS BY COUNTRY

PATENTS ISSUED BY PATENT HOLDER

OVERVIEW

PROFILES

List of Tables

Summary Table : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021

Table 1 : GESTATION PERIODS OF SELECT COMMON SPECIES

Table 2 : LIFESPAN OF COMMON AVIAN SPECIES OF PETS

Table 3 : STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016

Table 4 : ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016

Table 5 : REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017

Table 6 : TOP BROILER PRODUCING STATES, 2015

Table 7 : TOP RED MEAT PRODUCING STATES, 1990 AND 2015

Table 8 : DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015

Table 9 : CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015

Table 10 : HORSE (EQUINE) POPULATION BY COUNTRY, 2016

Table 11 : CATTLE (BOVINE) POPULATION BY COUNTRY, 2016

Table 12 : PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016

Table 13 : COMMON EXAMPLES OF ZOONOTIC DISEASES

Table 14 : AFFECTED PIONEER ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES

Table 15 : ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014

Table 16 : APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS

Table 17 : PET INSURANCE PLAN COMPARISONS, UNITED STATES

Table 18 : NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015

Table 19 : ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015

Table 20 : GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021

Table 21 : GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021

Table 22 : GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021

Table 23 : GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016

Table 24 : HENDRA VIRUS EQUINE INCIDENTS

Table 25 : BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES

Table 26 : ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES

Table 27 : MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES

Table 28 : MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES

Table 29 : ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES

Table 30 : BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 31 : BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 32 : ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 33 : MERCK & CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 34 : MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 35 : ZOETIS' PRODUCTION ANIMAL VACCINES BY TARGET SPECIES

Table 36 : GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2021

Table 37 : GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, THROUGH 2021

Table 38 : GLOBAL MARKET FOR ANIMAL PHARMACEUTICALS BY REGION, THROUGH 2021

Table 39 : GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS, 2016

Table 40 : BOEHRINGER INGELHEIM'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 41 : ELANCO'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 42 : HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 43 : HUVEPHARMA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 44 : VIRBAC'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 45 : ZOETIS' ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES

Table 46 : BAYER'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 47 : BOEHRINGER INGELHEIM'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 48 : ECO ANIMAL HEALTH'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 49 : ELANCO'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 50 : ESTEVE'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 51 : MERCK'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 52 : MERIAL'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 53 : VIRBAC'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 54 : ZOETIS' ANTI-INFECTIVE DRUGS BY TARGET SPECIES

Table 55 : ARATANA THERAPEUTICS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 56 : BAYER ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 57 : BOEHRINGER INGELHEIM'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 58 : ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 59 : ESTEVE'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 60 : MERCK'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 61 : MERIAL'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 62 : ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES

Table 63 : ARATANA THERAPEUTICS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 64 : BAYER'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 65 : BOEHRINGER INGELHEIM'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 66 : MERCK'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 67 : MERIAL'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 68 : VIRBAC'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 69 : ZOETIS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES

Table 70 : BAYER'S PARASITICIDES BY TARGET SPECIES

Table 71 : BEAPHAR'S PARASITICIDES BY TARGET SPECIES

Table 72 : BOEHRINGER INGELHEIM'S PARASITICIDES BY TARGET SPECIES

Table 73 : ECO ANIMAL HEALTH'S PARASITICIDES BY TARGET SPECIES

Table 74 : ELANCO'S PARASITICIDES BY TARGET SPECIES

Table 75 : PARASITICIDES BY TARGET SPECIES

Table 76 : MERCK'S PARASITICIDES BY TARGET SPECIES

Table 77 : MERIAL'S PARASITICIDES BY TARGET SPECIES

Table 78 : VIRBAC'S PARASITICIDES BY TARGET SPECIES

Table 79 : ZOETIS' PARASITICIDES BY TARGET SPECIES

Table 80 : ELANCO'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES

Table 81 : VETOQUINOL'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES

Table 82 : ZOETIS' PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES

Table 83 : BAYER'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 84 : BOEHRINGER INGELHEIM'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 85 : ELANCO'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 86 : ESTEVE'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 87 : HBO2 THERAPEUTICS' OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 88 : MERCK'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 89 : MERIAL'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 90 : VIRBAC'S OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 91 : ZOETIS' OTHER PHARMACEUTICALS BY TARGET SPECIES

Table 92 : DENTAL PHARMACEUTICALS BY TARGET SPECIES AND PROVIDER

Table 93 : GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2021

Table 94 : GLOBAL MARKET FOR FEED ADDITIVES BY ANIMAL GROUP, THROUGH 2021

Table 95 : GLOBAL MARKET FOR ANIMAL FEED ADDITIVES BY REGION, THROUGH 2021

Table 96 : GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016

Table 97 : ADISSEO'S AMINO ACIDS BY TARGET SPECIES

Table 98 : AJINOMOTO'S AMINO ACIDS BY TARGET SPECIES

Table 99 : BOEHRINGER INGELHEIM'S AMINO ACIDS BY TARGET SPECIES

Table 100 : EVONIK'S AMINO ACIDS BY TARGET SPECIES

Table 101 : NOVUS INTERNATIONAL'S AMINO ACIDS BY TARGET SPECIES

Table 102 : MEDICINAL ADDITIVES BY TARGET SPECIES

Table 103 : ELANCO'S MEDICINAL ADDITIVES BY TARGET SPECIES

Table 104 : MERCK'S MEDICINAL ADDITIVES BY TARGET SPECIES

Table 105 : MERIAL'S MEDICINAL ADDITIVES BY TARGET SPECIES

Table 106 : PHIBRO'S MEDICINAL ADDITIVES BY TARGET SPECIES

Table 107 : ZOETIS' MEDICINAL ADDITIVES BY TARGET SPECIES

Table 108 : ADISSEO (BLUESTAR) NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 109 : BAYER'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 110 : BASF'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 111 : BEAPHAR'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 112 : BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 113 : DSM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 114 : ELANCO'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 115 : ESTEVE'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 116 : HESKA'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 117 : MOSAIC'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 118 : NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

Table 119 : ADISSEO'S VITAMINS AND MINERALS BY TARGET SPECIES

Table 120 : BASF'S VITAMINS AND MINERALS BY TARGET SPECIES

Table 121 : BEAPHAR'S VITAMINS AND MINERALS BY TARGET SPECIES

Table 122 : DSM'S VITAMINS AND MINERALS BY TARGET SPECIES

Table 123 : MERCK'S VITAMINS AND MINERALS BY TARGET SPECIES

Table 124 : ZOETIS' VITAMINS AND MINERALS BY TARGET SPECIES

Table 125 : GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2021

Table 126 : GLOBAL MARKET FOR ANIMAL DIAGNOSTIC PRODUCTS BY ANIMAL GROUP, THROUGH 2021

Table 127 : GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY REGION, THROUGH 2021

Table 128 : GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS SUPPLIERS BASED ON COMPETITOR REVENUES, 2016

Table 129 : ABAXIS' DIAGNOSTICS BY TARGET SPECIES

Table 130 : BEAPHAR'S DIAGNOSTICS BY TARGET SPECIES

Table 131 : HESKA'S DIAGNOSTICS BY TARGET SPECIES

Table 132 : IDEXX'S DIAGNOSTICS BY TARGET SPECIES

Table 133 : MERCK'S DIAGNOSTICS BY TARGET SPECIES

Table 134 : VIRBAC'S DIAGNOSTICS BY TARGET SPECIES

Table 135 : ZOETIS' DIAGNOSTICS BY TARGET SPECIES

Table 136 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2021

Table 137 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP THROUGH 2021

Table 138 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, THROUGH 2021

Table 139 : GLOBAL MARKET SHARES AND REVENUE OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER, 2016

Table 140 : MAJOR INDUSTRY PARTICIPATION BY ANIMAL HEALTH SUPPLIERS

Table 141 : ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016

Table 142 : DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER’S COUNTRY, JAN. 1, 1976-OCT. 1, 2016

Table 143 : DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER, JAN. 1, 1976-OCT. 1, 2016

Table 144 : COMPETITOR MARKET POSITION IN ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SEGMENT, 2016

List of Figures

Summary Figure : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, 2014-2021

Figure 1 : NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS 2015

Figure 2 : ESTIMATED NUMBER OF VETERINARIANS IN THE UNITED STATES BY GENDER* AND YEAR, 2009-2015

Figure 3 : GLOBAL MARKET SHARES OF ANIMAL VACCINES BY ANIMAL GROUP, 2016

Figure 4 : GLOBAL MARKET SHARES OF ANIMAL VACCINES BY REGION, 2016

Figure 5 : GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016

Figure 6 : BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 7 : MERCK'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 8 : MERIAL'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 9 : ZOETIS' COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 10 : GLOBAL MARKET FOR COMPANION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021

Figure 11 : GLOBAL REVENUES FOR COMPANION ANIMAL VACCINES BY TYPE, 2014-2021

Figure 12 : BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 13 : ELANCO'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 14 : MERCK'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 15 : MERIAL'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 16 : ZOETIS' PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 17 : GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021

Figure 18 : GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY TYPE, 2014-2021

Figure 19 : GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2016-2021

Figure 20 : GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, 2016

Figure 21 : GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICALS BY REGION, 2016

Figure 22 : GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS BASED ON COMPETITOR REVENUES, 2016

Figure 23 : ZOETIS' ALLERGY AND RESPIRATORY DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 24 : GLOBAL MARKET FOR ALLERGY AND RESPIRATORY PRODUCTS BY ANIMAL GROUP, 2014-2021

Figure 25 : BAYER'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 26 : ELANCO'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 27 : MERCK'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 28 : ZOETIS' ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 29 : GLOBAL MARKET FOR ANTI-INFECTIVES BY ANIMAL GROUP, 2014-2021

Figure 30 : ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 31 : ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 32 : GLOBAL MARKET FOR ANTI-INFLAMMATORIES AND ANALGESICS BY ANIMAL GROUP, 2014-2021

Figure 33 : MERCK'S METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES

Figure 34 : ZOETIS' METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 35 : GLOBAL MARKET FOR METABOLIC DRUGS BY ANIMAL GROUP, 2014-2021

Figure 36 : BAYER'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 37 : ELANCO'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 38 : MERCK'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 39 : MERIAL'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 40 : ZOETIS' PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 41 : GLOBAL MARKET FOR PARASITICIDES BY ANIMAL GROUP, 2014-2021

Figure 42 : GLOBAL MARKET FOR PSYCHOTROPICS BY ANIMAL GROUP, 2014-2021

Figure 43 : ZOETIS' OTHER PHARMACEUTICALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 44 : GLOBAL MARKET FOR OTHER PHARMACEUTICALS BY ANIMAL GROUP, 2014-2021

Figure 45 : GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2014-2021

Figure 46 : GLOBAL MARKET SHARES OF FEED ADDITIVES BY ANIMAL GROUP, 2016

Figure 47 : GLOBAL MARKET SHARES OF ANIMAL FEED ADDITIVES BY REGION, 2016

Figure 48 : GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016

Figure 49 : GLOBAL MARKET FOR AMINO ACIDS BY ANIMAL GROUP, 2014-2021

Figure 50 : ELANCO'S MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 51 : ZOETIS' MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 52 : GLOBAL MARKET FOR MEDICINAL FEED ADDITIVES BY ANIMAL GROUP, 2014-2021

Figure 53 : BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES

Figure 54 : ELANCO'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 55 : GLOBAL MARKET FOR NUTRITIONAL SUPPLEMENTS BY ANIMAL GROUP, 2014-2021

Figure 56 : ZOETIS' VITAMINS AND MINERALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 57 : GLOBAL MARKET FOR VITAMINS AND MINERALS BY ANIMAL GROUP, 2014-2021

Figure 58 : GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, 2014-2021

Figure 59 : GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY ANIMAL GROUP, 2016

Figure 60 : GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY REGION, 2016

Figure 61 : GLOBAL MARKET SHARE OF ANIMAL DIAGNOSTICS BY COUNTRY, 2016

Figure 62 : GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTIC SUPPLIERS BASED ON COMPETITOR REVENUES, 2016

Figure 63 : HESKA'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES

Figure 64 : IDEXX'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES

Figure 65 : VIRBAC'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 66 : ZOETIS' DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016

Figure 67 : ZOETIS' FELINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 68 : ZOETIS' CANINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 69 : ZOETIS' EQUINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 70 : ZOETIS' RUMINANT DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 71 : ZOETIS' SWINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 72 : ZOETIS' AVIAN DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016

Figure 73 : GLOBAL MARKET FOR RAPID DIAGNOSTIC TESTS BY ANIMAL GROUP, 2014-2021

Figure 74 : GLOBAL MARKET FOR RAPID DIAGNOSTICS BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021

Figure 75 : GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY ANIMAL GROUP, 2014-2021

Figure 76 : GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021

Figure 77 : GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT AND RELATED MATERIALS BY ANIMAL GROUP, 2014-2021

Figure 78 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2014-2021

Figure 79 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2014-2021

Figure 80 : GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2016

Figure 81 : GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2014-2021

Figure 82 : GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2016

Figure 83 : GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SELECT COUNTRY, 2016

Figure 84 : GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2016

Figure 85 : ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016

Purchase this Market Research Report

  • SINGLE USER LICENSE
    Single user license allows one specific user to access the product.
  • TEAM LICENSE
    Team License allows multiple users to access the product.
  • CORPORATE LICENSE
    Corporate License allows users across the whole organization to access the product.

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?